Fundraising Fox
/People
Sign in

Karen Liu

Investor

Partner at 3E Bioventures Capital · Board director at Apexigen · Board director at OncoImmune

Eindhoven, North Brabant, Netherlands

Find your path to Karen

324 people in our graph share verified history with Karen — schools, employers, funds. One of them is your warm intro.

Natalie WisniewskiunlockedKaren: together at Profusa (2015–2019)
Karen: together at Shantonpharma
×6Karen: together at McKinsey & Company
×4Karen: together at 3E Bioventures Capital

About

Karen Liu is a Partner at 3E Bioventures, a firm that allocates approximately half of its investments to biotech and half to TechBio, which applies cross-disciplinary technologies to biology across areas including devices, diagnostics, and life science tools. Her work focuses on funding health innovation and supporting entrepreneurs developing therapies and products.

Contact· self-published, not guessed

Board director at Apexigen

Intro paths

→

In turn, Karen can intro founders to Apexigen's investors below.

Apexigen's investors · 6

3E Bioventures CapitalPalo Alto · since 2018Decheng CapitalMenlo Park · since 2018EFung CapitalShenzhen · since 2019ShangBay Capital LLCPalo Alto · since 2019Sv Tech Ventures, Inc.Palo Alto · since 2018Virtus Inspire Venturessince 2018

Co-founders at Apexigen

XY
Xiaodong YangPresident, CEO and Secretary

Board director at OncoImmune

Intro paths

→

In turn, Karen can intro founders to OncoImmune's investors below.

OncoImmune's investors · 3

3E Bioventures CapitalPalo Alto · since 2017HM Venture PartnersSan Francisco · since 2017National Institutes of Health (NIH)since 2014

Co-founders at OncoImmune

PZ
Pan ZhengExecutive Officer
YL
Yang LiuExecutive Officer, Director

Experience

  1. 3E BioventuresPartnercurrent2015 — present
  2. Dermaliq Therapeutics, Inc.Board Membercurrent2022 — present
  3. Galaxy Brain ScientificBoard Membercurrent2021 — present
  4. Shanton PharmaBoard Membercurrent2021 — present
  5. Rapafusyn PharmaceuticalsBoard Membercurrent2021 — present
  6. Purinomia BiotechBoard Membercurrent2020 — present
  7. Avirmax, Inc.Board Membercurrent2020 — present
  8. Quadriga BioSciences, Inc.Board Membercurrent2017 — present
  9. ProfusaBoard Member2015 — 2022
  10. Kaiwu CapitalPartner2011 — 2015Beijing City, China
  11. CRCIMD/Director/VP2007 — 2011
  12. 3721.com (Inter China Network Software)COO/ acting CFO /SVP2000 — 2004Beijing City, China
  13. McKinsey & CompanyAssociate / Project manager1998 — 2000Beijing City, China

Skills & more

Venture Capital54Strategy4Start-ups12Biotechnology14Life Sciences2Lifesciences13Business Strategy2Investments3

From Karen's professional profile.

Colleagues at 3E Bioventures Capital

Francine Fang
Partner at 3E Bioventures Capital
Frank Yan
Partner at 3E Bioventures Capital
Joy Yang
Venture Partner at 3E Bioventures Capital
Melford Yuan
Partner at 3E Bioventures Capital

Frequently asked questions

Who is Karen Liu?
Karen Liu is a Partner at 3E Bioventures, a firm that allocates approximately half of its investments to biotech and half to TechBio, which applies cross-disciplinary technologies to biology across areas including devices, diagnostics, and life science tools. Her work focuses on funding health innovation and supporting entrepreneurs developing therapies and products.
Where does Karen Liu work?
Karen Liu is Partner at 3E Bioventures Capital and Board director at Apexigen and Board director at OncoImmune.
Where did Karen Liu go to school?
Karen Liu studied at Harvard University (Ph.D, Immunology); Harvard Medical School (MMS, Master of Medical Sciences); Cornell University (BS, Biochemistry).

Same school

Shared employers